ASX - By Stock
|
SVL |
Re:
Ann: Regional Exploration and Drilling at Bowdens Silver Project
|
|
Stryhard
|
14 |
7.6K |
0 |
30/09/23 |
30/09/23 |
ASX - By Stock
|
14
|
7.6K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Stryhard
|
1.3K |
540K |
6 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
1.3K
|
540K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Stryhard
|
3.4K |
1.1M |
2 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Stryhard
|
17K |
6.5M |
7 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Stryhard
|
10K |
3.0M |
10 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Stryhard
|
1.0K |
268K |
31 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
1.0K
|
268K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes
|
|
Stryhard
|
1.0K |
268K |
6 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
1.0K
|
268K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
the shorts will bail with margin calling and announcements due
|
|
Stryhard
|
482 |
119K |
0 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
482
|
119K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
the shorts will bail with margin calling and announcements due
|
|
Stryhard
|
482 |
119K |
5 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
482
|
119K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
I am not optimistic
|
|
Stryhard
|
7 |
2.0K |
1 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze for entrepreneurs
|
|
Stryhard
|
12 |
3.1K |
0 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze for entrepreneurs
|
|
Stryhard
|
12 |
3.1K |
0 |
20/06/21 |
20/06/21 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
KLL |
Re:
Ann: Beyondie SOP Project - Commissioning Update
|
|
Stryhard
|
514 |
168K |
11 |
14/06/21 |
14/06/21 |
ASX - By Stock
|
514
|
168K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Stryhard
|
796 |
392K |
15 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
392K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast Shareholder Pledge
|
|
Stryhard
|
2 |
1.5K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
2
|
1.5K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Nasal clarification-important reflection
|
|
Stryhard
|
11 |
3.6K |
5 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
11
|
3.6K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
SPL7013 Aerosol spray OMG
|
|
Stryhard
|
14 |
5.2K |
4 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
14
|
5.2K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
SPL7013 Aerosol spray OMG
|
|
Stryhard
|
14 |
5.2K |
6 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
14
|
5.2K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
Stryhard
|
23K |
13M |
5 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Raises A$75 Million
|
|
Stryhard
|
115 |
68K |
24 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
115
|
68K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Stryhard
|
17K |
6.5M |
11 |
30/11/19 |
30/11/19 |
ASX - By Stock
|
17K
|
6.5M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Stryhard
|
4.4K |
2.4M |
1 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
Stryhard
|
4.4K |
2.4M |
4 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Pharmaxis shareholders breathe easy – the FDA loves you
|
|
Stryhard
|
16 |
13K |
3 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
16
|
13K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to Present at RBC Global Healthcare Conference
|
|
Stryhard
|
33 |
13K |
15 |
22/05/19 |
22/05/19 |
ASX - By Stock
|
33
|
13K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2019
|
|
Stryhard
|
1 |
2.7K |
9 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
1
|
2.7K
|
9
|
|
ASX - By Stock
|
MSB |
MSB Trading 2019
|
|
Stryhard
|
1 |
2.7K |
7 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
1
|
2.7K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Competition/ experiment..prediction of MSB price @ close of business June 28 2019
|
|
Stryhard
|
135 |
53K |
3 |
12/04/19 |
12/04/19 |
ASX - By Stock
|
135
|
53K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Competition/ experiment..prediction of MSB price @ close of business June 28 2019
|
|
Stryhard
|
135 |
53K |
3 |
09/04/19 |
09/04/19 |
ASX - By Stock
|
135
|
53K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Who was in charge of liason with FDA
|
|
Stryhard
|
8 |
4.4K |
4 |
03/01/19 |
03/01/19 |
ASX - By Stock
|
8
|
4.4K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: US FDA requests further data for VivaGel BV approval
|
|
Stryhard
|
158 |
77K |
3 |
02/01/19 |
02/01/19 |
ASX - By Stock
|
158
|
77K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Corporate Review
|
|
Stryhard
|
49 |
24K |
1 |
28/12/18 |
28/12/18 |
ASX - By Stock
|
49
|
24K
|
1
|
|
Commodities
|
Biotech |
Re:
Biotech Analysts $4M pa
|
|
Stryhard
|
49 |
51K |
1 |
27/12/18 |
27/12/18 |
Commodities
|
49
|
51K
|
1
|
|
Commodities
|
Biotech |
Re:
Biotech Analysts $4M pa
|
|
Stryhard
|
49 |
51K |
2 |
27/12/18 |
27/12/18 |
Commodities
|
49
|
51K
|
2
|
|
ASX - By Stock
|
NMT |
Re:
Ann: Sale of Mt Marion equity for A$104M and retention of Offtake
|
|
Stryhard
|
73 |
41K |
7 |
23/12/18 |
23/12/18 |
ASX - By Stock
|
73
|
41K
|
7
|
|
ASX - By Stock
|
AMT |
A Current Affair...is that AMT?
|
|
Stryhard
|
1 |
1.9K |
1 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
1
|
1.9K
|
1
|
|
ASX - By Stock
|
AMT |
tumbleweeds
|
|
Stryhard
|
1 |
948 |
0 |
10/11/18 |
10/11/18 |
ASX - By Stock
|
1
|
948
|
0
|
|
ASX - General
|
Biotech |
Re:
Biotechs leading into Christmas
|
|
Stryhard
|
21 |
18K |
0 |
05/11/18 |
05/11/18 |
ASX - General
|
21
|
18K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Pharmaxis Earns A$15 Million Milestone Payment
|
|
Stryhard
|
9 |
6.3K |
13 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
9
|
6.3K
|
13
|
|
ASX - By Stock
|
SPL |
Re:
Shorters getting desparate!
|
|
Stryhard
|
32 |
9.3K |
1 |
15/08/17 |
15/08/17 |
ASX - By Stock
|
32
|
9.3K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Corporate world...
|
|
Stryhard
|
7 |
2.0K |
2 |
31/03/17 |
31/03/17 |
ASX - By Stock
|
7
|
2.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Corporate world...
|
|
Stryhard
|
7 |
2.0K |
3 |
31/03/17 |
31/03/17 |
ASX - By Stock
|
7
|
2.0K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Why not an Aztrazenica buyout
|
|
Stryhard
|
7 |
1.9K |
6 |
27/03/17 |
27/03/17 |
ASX - By Stock
|
7
|
1.9K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Next Announcement
|
|
Stryhard
|
126 |
33K |
11 |
22/02/17 |
22/02/17 |
ASX - By Stock
|
126
|
33K
|
11
|
|
ASX - By Stock
|
NMT |
Re:
Ann: Ceasing to be a substantial holder
|
|
Stryhard
|
39 |
14K |
7 |
15/02/17 |
15/02/17 |
ASX - By Stock
|
39
|
14K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Next Announcement
|
|
Stryhard
|
126 |
33K |
5 |
08/02/17 |
08/02/17 |
ASX - By Stock
|
126
|
33K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Conferences galore in Biotech USA - Where is Jackie
|
|
Stryhard
|
9 |
3.2K |
1 |
19/01/17 |
19/01/17 |
ASX - By Stock
|
9
|
3.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Phase 1's UK shenanigans
|
|
Stryhard
|
21 |
4.7K |
4 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
21
|
4.7K
|
4
|
|
ASX - By Stock
|
NMT |
Re:
Dom360
|
|
Stryhard
|
55 |
23K |
6 |
30/08/16 |
30/08/16 |
ASX - By Stock
|
55
|
23K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Change in Director's Interest Notice - R Thomas-SPL.AX
|
|
Stryhard
|
24 |
4.8K |
1 |
23/05/16 |
23/05/16 |
ASX - By Stock
|
24
|
4.8K
|
1
|
|